LABS MediPharm Labs Corp.
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products. In addition, the company offers cannabis related medical information and services; and cannabis clinic services for patients requiring medical cannabis education and prescriptions. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.…
Industry Peers
Drug Manufacturers - Specialty & GenericKey Statistics
About MediPharm Labs (TSE: LABS)
›
MediPharm Labs (TSE: LABS) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 127 employees.
The shares were at 0.0550 CAD on 19 November 2026, down 21.4% over 52 weeks. Its 52-week range is 0.0550 CAD to 0.1000 CAD, and it trades at the bottom of that range.
Its market capitalisation is 23.49M CAD.
MediPharm Labs reports return on equity of -23.1%, an operating margin of -4.3% and revenue up 3.1% year over year.
It holds more cash than debt, a net cash position of 9.78M CAD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. The next earnings report is expected on 29 March 2027.